Our
Speakers (A-Z)
Chris Callewaert
Senior Post-doctoral Researcher at Ghent University, Belgium
Dr. Chris Callewaert is senior postdoctoral research fellow of the Research Foundation Flanders (FWO) at Ghent University, Belgium. He studies the skin microbiome and metabolome in health and disease. He is a pioneer in skin microbiome transplantation and skin bacteriotherapy to solve body odor. Since the corona pandemic, he has also been training sniffer dogs to detect COVID19 infection from people’s sweat, with >95% accuracy.
Chrysi Sergaki
Microbiome Scientist at National Institute for Biological Standards and Control (NIBSC/MHRA)
Dr Chrysi Sergaki is a scientist in the Microbiome section at the National Institute for Biological Standards and Control (NIBSC), working on microbial interactions and how to utilise them for the benefit of human health.
At NIBSC, Chrysi is leading projects investigating the role of the microbiome in gut health and disease. Furthermore, she is leading the development of reference reagents that can act as global standards and will be evaluated as candidates for the first World Health Organization Whole Cell Reference Reagents for the microbiome.
Daniel Brownell
Director, Research & Development at AOBiome Therapeutics
Daniel Brownell currently serve as the Director of R&D at AOBiome, responsible for preclinical research, study execution, and clinical support. Previously, he have served as the Director of R&D and Manufacturing at Sample6, who developed a line of rapid diagnostics for the food safety industry.
Eline Klaassens
Product Manager Human Health at BaseClear B.V.
Eline is product manager Human Health at BaseClear and specialises in offering expert advice in refining research questions, hypotheses, consultancy in study design including sampling, analysing the microbial data and interpretation of the generated data. Eline has a strong background in human microbiome analysis, holding a PhD degree from Wageningen University in Microbial Eco-physiology of the human intestinal tract.
George Paraskevakos
Executive Director at International Probiotics Association (IPA)
George is the executive director of the International Probiotics Association (IPA). George has been involved with the probiotic industry since 2007 where he served in various roles from business development to account management with a globally recognized probiotic producer. During this time, he also served on the IPA Board of Directors and had two (2) mandates as President before taking on the association’s leadership role as Executive Director in 2015.
Greg Hillebrand
Senior Principal Research Scientist at Amway
Greg Hillebrand is a Senior Principal Research Scientist for Amway where he provides technical leadership for the company’s skin and oral microbiome clinical research and product development initiatives.
Jean-Pol Warzée
President at European Scientific League for Probiotics – ESLP
With more than 20 years experience in the microbiota and microbiotics area, Jean-Pol G. Warzée, Medical Doctor has participated to many research and development projects in human health ( by elderly people, cystic fibrosis, …) and also in animal health in collaboration with Research Centers and Universities. Jean-pol has collaborated to the development of new microbiotics solutions and is author, co-author of many publications.
Lionel Breton
Cofounder and executive VP of IDEC therapeutics
Lionel Breton got a PhD in 1982 in general Endocrinology in the lab of R.Michel and J.Roche at College de France in Paris. Than, he got a State Doctorate in general Pharmacology in Poitiers Hospital/ school of medicine in 1985 After a 1st position in Servier Laboratory as Project leader in neuro-pharmacology. He is also visiting Professor/affiliate member in the prestigious University McGill in Montreal.
Marcus Claesson
Chief Executive Officer at SeqBiome
After a BSc in Chemical Engineering and MSc in Bioinformatics at Chalmers University of Technology in Gothenburg, Marcus completed his PhD at University College Cork (UCC) sequencing and comparing commensal Lactobacillus species. This was followed by postdoctoral fellowships mining probiotic bacteria and analysing the microbiomes of older people as part of the ELDERMET project. Marcus is now a PI at APC Microbiome Ireland, UCC, where his main research interests in the role of microbiota in inflammatory bowel disease, and methods development for 'omics' technologies.
Marie Drago
Founder at Gallinée
Marie Drago is a Doctor in Pharmacy and the founder of Gallinee Microbiome Skincare. Launched in 2016 in London, the brand has been caring for the skin and its microbiome though innovative products across a number of categories.
Momo Vuyisich
Founder and Chief Science Officer at Viome
Momo Vuyisich is a founder and Chief Science Officer of Viome. He is also an Adjunct Professor at the University of New Mexico and New Mexico Tech. Besides providing scientific leadership at Viome, Momo focuses on product development, clinical certification, and clinical research.
Newton Gomes
Researcher University of Aveiro/Co-founder at InnerCore Microbiome
Newton Gomes is a scientist and entrepreneur who is passionate about linking research on environmental and applied microbiology to technological innovation and entrepreneurship. His professional experience includes 6 years as a researcher at the Julius Kühn-Institut (JKI) (Braunschweig, Germany) and more than 14 years as researcher at the Department of Biology and the Centre for Environmental and Marine Studies (CESAM) (University of Aveiro, Portugal).
Pavlovic Guillaume
Head of Unit at PHENOMIN-ICS
Dr Guillaume Pavlovic is the Head of the mouse and rat model creation core & microbiota service at Institut Clinique de la Souris (ICS) – PHENOMIN. He direct the generation and validation of genetically rodent mutants and animal model microbiota research. He leads R&D programmes focusing on the development of new tools for genetic engineering and microbiota analyses, and is an expert in genetics and genome editing including the CRISPR/Cas system.
Sergio Esteban
Project Manager at Probisearch SLU
Sergio Esteban obtained his Ph.D in Molecular Bioscience from the Universidad Autonoma de Madrid (UAM) in 2018. He has a strong scientific investigation background working with different Researching Groups in the fields of cardiovascular, immune and oncology diseases. Most recently, he has joined to the pharmaceutical industry working as Project Manager at Probisearch. Probisearch is a company born to develop new probiotics for animal and human Health.
Veronika Oudova
Co-founder and Chief Executive Officer at S-Biomedic
Veronika Oudova is a co-founder and Chief Executive Officer of S-Biomedic.
Veronika completed a master study in International Trade in Prague and a master in International Management within the program CEMS located in Prague, Vienna and Rotterdam. After her studies she has worked as project manager and marketing consultant at Cord Blood Bank Czech Republic. There she also co-founded a spin-off company StemCellPro.
